History of Present Illness: 66yM with COPD on home O2 and chronic steroids, CAD, VRE UTIs and chronic back pain admitted for SOB.
Of note, recent ED discharge for lower back pain/incontinence with MR L spine done which revealed no significant change since [**2101-11-30**] with no evidence of canal stenosis or compression of the conus or the cauda equina and and L5/S1 disc bulge causing moderate left foraminal stenosis with impingement of the exiting nerve root.
ED course: CXR revealed large lung volumes without infiltrate or evidence of CHF.
His O2 sats were 95% on 4L N/C (baseline O2).
Pertinent Results: [**2105-8-11**] 10:35AM BLOOD WBC-21.8*# RBC-4.66 Hgb-13.0* Hct-41.1 MCV-88 MCH-28.0 MCHC-31.7 RDW-14.7 Plt Ct-523*# [**2105-8-11**] 10:35AM BLOOD Neuts-69.7 Lymphs-22.7 Monos-4.7 Eos-2.2 Baso-0.7 [**2105-8-11**] 10:35AM BLOOD Plt Ct-523*# [**2105-8-11**] 10:35AM BLOOD Glucose-133* UreaN-16 Creat-0.7 Na-141 K-4.1 Cl-98 HCO3-33* AnGap-14 [**2105-8-11**] 10:35AM BLOOD CK-MB-4 cTropnT-<0.01 [**2105-8-11**] 10:35AM BLOOD Calcium-10.1 Phos-4.6* Mg-2.0 [**2105-8-12**] 11:11AM BLOOD %HbA1c-5.7 [**2105-8-11**] 12:02PM BLOOD Type-ART pO2-105 pCO2-68* pH-7.32* calTCO2-37* Base XS-6 [**2105-8-11**] 10:54AM BLOOD Lactate-2.4*  CXR ([**2105-8-11**]): The lungs are hyperexpanded consistent with underlying obstructive lung disease.
Brief Hospital Course: IMPR/PLAN: The patient is a 66 year old man with COPD on home O2 and chronic steroids, CAD, VRE UTIs, and chronic back pain admitted for COPD exacerbation that occurred while he was being positioned prone in the [**First Name4 (NamePattern1) 1193**] [**Last Name (NamePattern1) 1194**] Center.
NSTEMI ([**2101**]) [**4-9**] with cath normal, TTE with preserved biventricular function.
Boost shake 1 can qd  Discharge Medications: 1.
Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Two (2) Tablet PO DAILY (Daily).
[**First Name4 (NamePattern1) 122**] [**Last Name (NamePattern1) 8499**] at [**Telephone/Fax (1) 7976**] or come the the ER if you have any symptoms that concern you such as shortness of breath, increased oxygen or inhaler requirements, chest pain, or unresolving abdominal or back pain.
Followup Instructions: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 10134**], MD Phone:[**Telephone/Fax (1) 7976**] Date/Time:[**2105-8-17**] 2:15 .
Provider: [**Name10 (NameIs) 13368**] [**Last Name (NamePattern4) 13369**], MD Phone:[**Telephone/Fax (1) 1091**] Date/Time:[**2105-10-2**] 8:20 .
